Skip to content

Clinical Effect of Local Application of a Fusion Protein on Diabetic Foot Ulcers

Clinical Effect of Local Application of a Fusion Protein on Diabetic Foot Ulcers: a multi-center, prospective, randomized control study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006860
Enrollment
Unknown
Registered
2015-08-02
Start date
2015-08-15
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic foot

Interventions

Experimenta:application of the Fusion Protein, 3 times a day, for a period of 4 weeks.
control:application of sterile normal saline, 3 times a day, for a period of 4 weeks.

Sponsors

General Hospital of Jinan Military Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. aged 18-70 years; 2. type 1 or 2 diabetes mellituswhose blood sugar levels could be controlled; 3. Wagner's grades 1 and 2 DFU, no infection except the diabetic food ulcer; 4. Adequate arterial blood flow at the corresponding limb as evidenced by an ankle brachial index (ABI) of > 0.8 and =20 mmHg must be present; 5. A target ulcer which is not less than 1 cm2; 6. Willing and able to follow instructions; 7. signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Lactating and pregnant women, and those of childbearing potential not using reliable contraceptive methods; 2. surgical procedure other than debridement on the study ulcer foot in 4 weeks; 3. Patients with acute complications; 4. Patients with stroke or Lumbar diseases resulting in obstacles of consciousness or movement of Lower limbs; 5. Malignant lesions in the ulcer; 6. malnutrition ,Hemoglobin(HB)=180/110mmHg; 8. With serious abnormal function of heart, liver, kidney and other vital organs; 9. alcohol or drug abuse; 10. Expected lifetime is no more than 6 months; 11. medical conditions that in the justified opinion of the investigator would make the patient an inappropriate candidate for the study.

Design outcomes

Primary

MeasureTime frame
Rate of healed wound;

Secondary

MeasureTime frame
healing time of the wound;quantificated indexes;the total effective rate;Changing rate of the wound size;

Countries

China

Contacts

Public ContactQingying Chen

General Hospital of Jinan Military Command

lvhx816@163.com+86 531 51666135

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026